#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans cell sarcoma Glycogen storage disease type I Polycystic liver disease Cholestatic pruritus Pneumonia Leber's congenital amaurosis Hereditary spastic paraplegia Oesophageal adenocarcinoma Cervix carcinoma recurrent Autoimmune myositis Liposarcoma metastatic Chorioretinitis Alternating hemiplegia of childhood Antiphospholipid syndrome Medullary thyroid cancer More trials…

    Learn about Rare Diseases

    Optic glioma – Trials in Disease Retinitis pigmentosa – Trials in Disease Amyotrophic lateral sclerosis – Trials in Disease Angiosarcoma non-metastatic X-linked lymphoproliferative syndrome – Treatment Mucopolysaccharidosis – Basic Information Breast angiosarcoma – Basic Information Adrenocortical carcinoma – Diagnostics Andersen-Tawil syndrome – Trials in Disease Crigler-Najjar syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Butyrate Trastuzumab Emtansine Mycophenolic Acid Pegenzileukin Ozanimod Hydrochloride Nemtabrutinib Imlifidase Tilsotolimod Sodium Propylene Glycol Topiramate Gilteritinib GSK4524101A Sulfamethoxazole Guselkumab IBANDRONIC ACID Amisulpride Tralokinumab SODIUM HYDROXIDE Thiamazole Teverelix More therapies…

    Learn about Your Condition

    Lymphangioleiomyomatosis Spondylolisthesis Infertility Erythema migrans Amyotrophic lateral sclerosis Aphthous ulcer Graves' disease Radius fracture Indolent systemic mastocytosis Haemorrhage prophylaxis Rectosigmoid cancer Hip arthroplasty Pharyngeal cancer stage III Oesophageal achalasia Glanzmann's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of early dapagliflozin treatment to reduce heart damage in patients with acute heart attack and reduced heart pumping function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study of safinamide compared to placebo for pain relief in patients with Parkinson’s disease who experience motor fluctuations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Safinamide
    Italy

  • Study of early versus late risankizumab treatment to evaluate immune cell response in patients with moderate to severe psoriasis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Risankizumab
    Spain

  • Evaluating the effectiveness of icatibant in reducing propofol injection pain in healthy adult volunteers

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Icatibant
    • Propofol
    • Sodium Chloride
    Norway

  • Study of botulinum toxin type A injections to prevent scarring in patients after heart surgery with sternotomy

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride Solution 0.9%
    • Botulinum Toxin Type A
    France

  • Comparison of Etacizine and Propafenone for maintaining normal heart rhythm in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Propafenone Hydrochloride
    Latvia
Previous Page
1 … 787 788 789 790 791 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!